Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. Approximately 10 percent of ...

About 100,000 Americans have sickle cell disease (SCD), the most common inherited blood disorder in the US. Roughly 10% of ...

September 18, 2024 (Houston Style Magazine) — In a historic move aimed at spotlighting a vital public health issue, the U.S. Department of Health and Human Services (HHS) will hold its first-ever ...

Labeled an orphan disease in the U.S., sickle cell disease (SCD) has historically been understudied and underfunded. As a result, effective therapeutics have lagged. Only one medication existed on the ...

Sickle cell disease (SCD) is an inherited health condition that slows the flow of red blood cells in your body. For people with SCD, hemoglobin S (a mutated protein that transports oxygen) causes red ...

In a recent review published in Nutrients, researchers assessed nutrition-related studies involving sickle cell disease (SCD) patients, particularly those in Africa. SCD, a congenital blood condition, ...

Novo Nordisk is gearing up to submit its rare blood disorder drug to the FDA after the former Forma Therapeutics asset reduced a painful complication of sickle cell disease (SCD) in a phase 3 study.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY ® ...

Today is World Sickle Cell Disease Day. The international awareness day is observed annually to increase public knowledge and an understanding of sickle cell disease and the challenges experienced by ...

The agreement ensures sustainable access to this innovative therapy for eligible patients ages 12 years and older in Germany- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today ...